🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 578784100
- IPO
- 1/31/2025 · $16.00/share
Business: Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with common diseases, with a focus on renal, cardiovascular and related metabolic, including obesity.
Company Contact
- CEO
- Jason Coloma
- Headquarters
- 171 Oyster Point Blvd., Suite 300, South San Francisco, CA 94080
- Phone
- 650-850-5070
- Investor Relations
- Jillian Connell · 650-650-5080 · jconnell@mazetx.com